Treatment of fibrosing cholestatic hepatitis with lamivudine

Slides:



Advertisements
Similar presentations
Serum immunoglobulin a from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation Tuula Halttunen, Markku Mäki.
Advertisements

Serum Hepatitis B Surface Antigen Quantitation Can Reflect Hepatitis B Virus in the Liver and Predict Treatment Response  Henry Lik–Yuen Chan, Vincent.
Volume 46, Issue 3, Pages (March 2007)
Hepatic Disease of Horses in the Western United States
Clinical Factors Associated With Liver Stiffness in Hepatitis B e Antigen–Positive Chronic Hepatitis B Patients  Grace Lai–Hung Wong, Vincent Wai–Sun.
Volume 38, Issue 1, Pages (January 2006)
Volume 50, Issue 4, Pages (April 2009)
Volume 117, Issue 1, Pages (July 1999)
Quiz Page June 2007 American Journal of Kidney Diseases
Incorrect Calculation and Inappropriate Interpretation: Accuracy of International Guidelines for Identifying Significant Fibrosis in e Antigen–Negative.
Acute hepatitis induced by greater celandine (Chelidonium majus)
First successful treatment of a primary high-grade gastric MALT lymphoma by eradication therapy for Helicobacter pylori  Stephan Timm, Marco Sailer, Karl–hermann.
Volume 141, Issue 4, Pages (October 2011)
Leptin, obesity, and liver disease
Volume 123, Issue 6, Pages (December 2002)
Suna Yapali, Nizar Talaat, Anna S. Lok 
Hepatitis B virus infection: Current status
Stephanos J. Hadziyannis  Journal of Hepatology 
Volume 119, Issue 1, Pages (July 2000)
Clinical Factors Associated With Liver Stiffness in Hepatitis B e Antigen–Positive Chronic Hepatitis B Patients  Grace Lai–Hung Wong, Vincent Wai–Sun.
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Quiz Page December 2007 American Journal of Kidney Diseases
Kevin O’Brien, Nadeem Hussain, Bradley A. Warady, David E
Volume 128, Issue 7, Pages (June 2005)
Maya Srivastava, Antonio Perez–Atayde, Maureen M. Jonas 
Volume 123, Issue 4, Pages (October 2002)
Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C  Chi–Jen Chu, Munira Hussain,
Donna M. Hepper, MD, Peggy Wu, MD, Milan J. Anadkat, MD 
Regression of Hepatic Fibrosis After Intestinal Transplantation in Total Parenteral Nutrition Liver Disease  M. Isabel Fiel, Bernhard Sauter, Hai–Shan.
Effect of Interferon-Gamma on Hepatic Fibrosis in Chronic Hepatitis B Virus Infection: A Randomized Controlled Study  Hong-Lei Weng, Bao-En Wang, Ji-Dong.
Volume 123, Issue 3, Pages (September 2002)
Volume 122, Issue 5, Pages (May 2002)
Volume 42, Issue 2, Pages (February 2005)
A. James Hanje, Lindsay J. Pell, Nicholas A. Votolato, Wendy L
Volume 114, Issue 1, Pages (January 1998)
Volume 120, Issue 4, Pages (March 2001)
Michel I. Kafrouni, Robert A. Anders, Sumita Verma 
Volume 126, Issue 1, Pages (January 2004)
Mallory–Denk Bodies Are Associated With Outcomes and Histologic Features in Patients With Chronic Hepatitis C  Mina O. Rakoski, Morton B. Brown, Robert.
Scott J. Cotler, Manish K. Dhamija, Fabiolla Siqueira, Anna H
Volume 115, Issue 5, Pages (November 1998)
Volume 128, Issue 2, (February 2005)
This Month in Gastroenterology
Hepatitis B Virus Load in Serum Does Not Reflect Histologic Activity in Patients With Decompensated Cirrhosis  Jin Dong Kim, Jong Young Choi, Si Hyun.
Volume 132, Issue 3, Pages (March 2007)
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Gastrointestinal Endoscopy  Volume 46, Issue 3, Pages (September 1997)
AGA technical review on celiac sprue
Infliximab-Associated Reversible Cholestatic Liver Disease
Hepatic Dysfunction in Sickle Cell Disease: A New System of Classification Based on Global Assessment  Philip A. Berry, Timothy J.S. Cross, Swee Lay Thein,
Volume 128, Issue 3, Pages (March 2005)
Volume 56, Issue 6, Pages (June 2012)
Progression of fibrosis in chronic hepatitis C
Volume 50, Issue 3, Pages (March 2009)
Suna Yapali, MD, Anna S. Lok, MD, FRCP 
Histological outcome during long-term lamivudine therapy
Volume 116, Issue 5, Pages (May 1999)
Serum Hepatitis B Surface Antigen Quantitation Can Reflect Hepatitis B Virus in the Liver and Predict Treatment Response  Henry Lik–Yuen Chan, Vincent.
Volume 126, Issue 7, Pages (June 2004)
Jia-Horng Kao*, Pei-Jer Chen*, Ming-Yang Lai*, Ding-Shinn Chen‡,§ 
Volume 156, Issue 3, Pages (February 2019)
Pathogenesis of cholestatic hepatitis C
Treatment of shiitake dermatitis by balneo PUVA therapy
Therapy with lamivudine and steroids in a patient with acute hepatitis B and rapidly progressive glomerulonephritis  V. Di Marco, S. De Lisi, M. Li Vecchi,
Quiz Page January 2010 American Journal of Kidney Diseases
Volume 120, Issue 4, Pages (March 2001)
Acute renal failure due to the herbal remedy CKLS
Fig. 4. Pathology of IgG4-related SC. A
Volume 125, Issue 6, Pages (December 2003)
Quiz Page September 2014 American Journal of Kidney Diseases
Presentation transcript:

Treatment of fibrosing cholestatic hepatitis with lamivudine Tak–Mao Chan*, Pui–Chee Wu‡, Fu–Keung Li*, Ching–Lung Lai*, Ignatius K.P. Cheng*, Kar–Neng Lai*  Gastroenterology  Volume 115, Issue 1, Pages 177-181 (July 1998) DOI: 10.1016/S0016-5085(98)70380-4 Copyright © 1998 American Gastroenterological Association Terms and Conditions

Fig. 1 Photomicrograph of liver biopsy specimen showing features of fibrosing cholestatic hepatitis characterized by marked hepatocyte balloon degeneration, focal hepatocyte loss, bile stasis, and pericellular fibrosis (H&E; original magnification 175×). Gastroenterology 1998 115, 177-181DOI: (10.1016/S0016-5085(98)70380-4) Copyright © 1998 American Gastroenterological Association Terms and Conditions

Fig. 2 Photomicrograph of liver biopsy specimen showing abundant HBcAg in both nuclei and cytoplasm by immunohistochemical staining (H&E; original magnification 175×). Gastroenterology 1998 115, 177-181DOI: (10.1016/S0016-5085(98)70380-4) Copyright © 1998 American Gastroenterological Association Terms and Conditions

Fig. 3 Photomicrograph of liver biopsy specimen showing HBsAg in the majority of hepatocytes by immunohistochemical staining (H&E; original magnification 175×). Gastroenterology 1998 115, 177-181DOI: (10.1016/S0016-5085(98)70380-4) Copyright © 1998 American Gastroenterological Association Terms and Conditions

Fig. 4 Diagram showing the serial levels of serum HBV DNA (□) and ALT (♢) and prothrombin time (○) in the patient. Lamivudine therapy was followed by a rapid reduction of HBV DNA and more gradual improvements in transaminasemia and liver function, the latter depicted by normalization of prothrombin time. Gastroenterology 1998 115, 177-181DOI: (10.1016/S0016-5085(98)70380-4) Copyright © 1998 American Gastroenterological Association Terms and Conditions